JPS6150926B2 - - Google Patents

Info

Publication number
JPS6150926B2
JPS6150926B2 JP54174017A JP17401779A JPS6150926B2 JP S6150926 B2 JPS6150926 B2 JP S6150926B2 JP 54174017 A JP54174017 A JP 54174017A JP 17401779 A JP17401779 A JP 17401779A JP S6150926 B2 JPS6150926 B2 JP S6150926B2
Authority
JP
Japan
Prior art keywords
group
pyridine
tetrahydro
thieno
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54174017A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5592317A (en
Inventor
Furansowa Anri Buranshaaru Jan
Panaku Edowaaru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parcor SARL
Original Assignee
Parcor SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parcor SARL filed Critical Parcor SARL
Publication of JPS5592317A publication Critical patent/JPS5592317A/ja
Publication of JPS6150926B2 publication Critical patent/JPS6150926B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
JP17401779A 1978-12-29 1979-12-29 Therapeutic composition having antithrombus and antiiblood platelet agglutination activity Granted JPS5592317A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7850359A GB2038625B (en) 1978-12-29 1978-12-29 Therapeutic composition having an antithrombotic and antiblood-platelet-aggregating activity

Publications (2)

Publication Number Publication Date
JPS5592317A JPS5592317A (en) 1980-07-12
JPS6150926B2 true JPS6150926B2 (enExample) 1986-11-06

Family

ID=10502010

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17401779A Granted JPS5592317A (en) 1978-12-29 1979-12-29 Therapeutic composition having antithrombus and antiiblood platelet agglutination activity

Country Status (9)

Country Link
US (1) US4537894A (enExample)
JP (1) JPS5592317A (enExample)
BE (1) BE880884A (enExample)
DE (1) DE2951671C2 (enExample)
FR (1) FR2445143A1 (enExample)
GB (1) GB2038625B (enExample)
IE (1) IE48884B1 (enExample)
IL (1) IL58817A (enExample)
IT (1) IT1162498B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01126782U (enExample) * 1988-02-24 1989-08-30

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749692A (en) * 1977-06-22 1988-06-07 Sanofi, S.A. Therapeutic compositions having anti-thrombotic and anti-blood-platelet-aggregating activity
US4602014A (en) * 1984-07-09 1986-07-22 Ciba-Geigy Corporation Ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives as benzodiazepine receptor modulators
ATE87479T1 (de) * 1989-01-04 1993-04-15 Savio Ist Biochim Naz Srl Lokal anzuwendende arzneizubereitungen enthaltend ticlopidine.
US5041430A (en) * 1989-09-18 1991-08-20 Du Pont Mereck Pharmaceutical Company Oral anticoagulant/platelet inhibitor low dose formulation
AU649885B2 (en) * 1991-10-01 1994-06-02 Nisshinbo Industries, Inc. Antithrombotic resin, tube, film and coating
EP1350511B1 (en) * 2000-12-25 2008-09-10 Daiichi Sankyo Company, Limited Medicinal compositions containing aspirin
CN103360408A (zh) * 2012-04-11 2013-10-23 中国人民解放军军事医学科学院毒物药物研究所 新的噻吩并吡啶类化合物及其医药用途
CN103374005B (zh) * 2012-04-11 2016-12-14 南京信诺泰医药有限公司 取代呋喃并哌啶衍生物的合成新方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215948B1 (enExample) * 1973-02-01 1976-05-14 Centre Etd Ind Pharma
FR2345150A2 (fr) * 1975-08-06 1977-10-21 Centre Etd Ind Pharma Nouveaux derives de la thienopyridine, et leur application
FR2307538A1 (fr) * 1975-04-18 1976-11-12 Centre Etd Ind Pharma Nouveau medicament anti-agregant plaquettaire
FR2315274A1 (fr) * 1975-06-27 1977-01-21 Parcor Nouveaux derives de la thieno (2,3-c) pyridine, leur preparation et leurs applications

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01126782U (enExample) * 1988-02-24 1989-08-30

Also Published As

Publication number Publication date
IT1162498B (it) 1987-04-01
GB2038625A (en) 1980-07-30
JPS5592317A (en) 1980-07-12
IT7951224A0 (it) 1979-12-28
FR2445143B1 (enExample) 1981-09-11
BE880884A (fr) 1980-06-27
IE792281L (en) 1980-06-29
IL58817A0 (en) 1980-02-29
IL58817A (en) 1982-09-30
GB2038625B (en) 1983-01-12
FR2445143A1 (fr) 1980-07-25
US4537894A (en) 1985-08-27
IE48884B1 (en) 1985-06-12
DE2951671A1 (de) 1980-07-17
DE2951671C2 (de) 1986-02-20

Similar Documents

Publication Publication Date Title
KR100598451B1 (ko) 동맥 혈전증의 치료와 예방을 위한 조성물과 그 조성물 단독 및/또는 혈소판 응집방지제와 결합한 인자 Ｘａ 억제제의 사용
NZ509647A (en) Farnesyl protein transferase inhibitors for treating arthropathies
JPH11501282A (ja) コリン受容体作用薬及び拮抗薬としてのエピバチジン及びその誘導体
EP1084125B1 (de) Kondensierte thienopyrimidine mit pde v inhibierender wirkung
JPS6150926B2 (enExample)
DE69425085T2 (de) Angiotensin II Antagonisten als prophylaktisches und therapeutisches Mittel für Nierenkrankheiten
CZ295801B6 (cs) Antitusické přípravky
JPS6126546B2 (enExample)
CA1220139A (en) Compounds, compositions and method of treatment for improving circulatory performance
US3519717A (en) Novel method for lowering high blood pressure and compositions therefor
JPH05132430A (ja) 薬物従属症及び禁断症状の治療に関するグリシン／ｎｍｄａレセプターリガンドの用法
DE3542794A1 (de) Antihypertensives kombinationspraeparat
US5234945A (en) Method of producing body weight and food intake using a dopamine D2 receptor agonist
US7101905B2 (en) Pharmaceutically active compounds and methods of use
SK155994A3 (en) Using of benzo/g/ quinolines
US4157394A (en) Cardio-protective pharmaceutical composition
US4749692A (en) Therapeutic compositions having anti-thrombotic and anti-blood-platelet-aggregating activity
CA1147658A (en) Therapeutic compositions having antithrombotic and anti-blood-platelet- aggregating activity
US4464377A (en) Anti-thrombotic therapeutic compositions
JPS6245525A (ja) 脂質低下剤
DE10010612A1 (de) Verwendung von PDE V-Inhibitoren
JP2003238405A (ja) 敗血症の処置に使用される薬剤組成物
JP2949366B2 (ja) 心臓疾患の予防または治療剤
US3824311A (en) Method of treatment
WO1998050037A1 (en) Anxiolytics